MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer
Cancer Science · 2024
DOI: 10.1111/cas.16196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Cuncun Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lung Neoplasms, Proto-Oncogene Proteins, Tumor Escape. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Clinical Collaboration Enhancement Program of Anhui Medical University, Research Program for Higher Education Institutions in Anhui Province, Postgraduate Innovation Research and Practice Program of Anhui Medical University.
Abstract (Originalsprache)
Multiple Endocrine Neoplasia 1 gene (MEN1 ), which is known to be a tumor suppressor gene in lung tissues, encodes a 610 amino acid protein menin. Previous research has proven that MEN1 deficiency promotes the malignant progression of lung cancer. However, the biological role of this gene in the immune microenvironment of lung cancer remains unclear. In this study, we found that programmed cell death‐ligand 1 (PD‐L1) is upregulated in lung‐specific Kras G12D mutation‐induced lung adenocarcinoma in mice, after Men1 deficiency. Simultaneously, CD8 + and CD3 + T cells are depleted, and their cytotoxic effects are suppressed. In vitro, PD‐L1 is inhibited by the overexpression of menin. Mechanistically, we found that MEN1 inactivation promotes the deubiquitinating activity of COP9 signalosome subunit 5 (CSN5) and subsequently increases the level of PD‐L1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Anhui Medical University, Hefei, China.
- Department of Pathology, Zhejiang Hospital, Hangzhou, China.
- Department of Microbiology, The Institute of Clinical Virology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Institute of Clinical Pharmacology, Anhui Medical University; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicin…
ORCID-Profile: Huan Qiu
Förderung
- Basic and Clinical Collaboration Enhancement Program of Anhui Medical University
- Research Program for Higher Education Institutions in Anhui Province
- Postgraduate Innovation Research and Practice Program of Anhui Medical University
- 2023 Postgraduate Youth Training Program of School of Nursing, Anhui Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Sun, N., Fei, Q., Peng, L., Wei, C., Liu, X., Miao, S., Chai, M., Wang, F., Wang, D., Hong, J., Huang, S., Zhang, S., & Qiu, H. (2024). MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer. Cancer Science. https://doi.org/10.1111/cas.16196
Vancouver
Zhang C, Sun N, Fei Q, Peng L, Wei C, Liu X, et al. MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer. Cancer Science. 2024. doi:10.1111/cas.16196
BibTeX
@article{Zhang2024,
author = {Zhang, Cuncun and Sun, Ningning and Fei, Qingze and Peng, Linlin and Wei, Chengyu and Liu, Xiangyu and Miao, Sainan and Chai, Mengqi and Wang, Fang and Wang, Di and Hong, Jingfang and Huang, Shenghai and Zhang, Shihao and Qiu, Huan},
title = {MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16196}
}
EUVIMED